comparemela.com

Latest Breaking News On - Pharma intelligence center - Page 3 : comparemela.com

Short Bowel Syndrome (SBS) Marketed and Pipeline Drugs

Summary. This reports provides a data-driven overview of the current and future competitive landscape in SBS therapeutics. .

New yorkUnited statesDevelopment stagePharma intelligence centerRoute of administrationBowel syndromePipeline drugs assessmentClinical trialsCompetitive landscapeMolecule typeTransition success rateVirtual componentsSite analyticsStrategic alliances

March 2023 CDMO Opportunities And Threats Report

Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities.

United kingdomEli lillyLaboratorios farmaceuticos roviAmbiopharm incVetter pharma fertigung gmbh coAllpack groupPfizer incKaryopharm therapeutics incSharp packaging servicesEvonik industriesBiopharma companyGilead sciences incAlmac group ltdAstrazeneca plcPharma ltdJohnson matthey plc

Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitiv

DUBLIN (BUSINESS WIRE) The "Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven overview of the current and future competitive landscape in ITP therapeutics.Ke.

Laura woodRoute of administrationE st office hours callPharma intelligence centerDevelopment stageOffice hours callPipeline drugs assessmentClinical trialsImmune thrombocytopeniaCompetitive landscapeMolecule typeManufacturer priceTransition success rateVirtual componentsSite analyticsStrategic alliances

GlobalData : US biotech IPO market yet to see previous high levels due to challenging market conditions, says GlobalData

06 Apr, 2023 US biotech IPO market yet to see previous high levels due to challenging market conditions, says GlobalData Share . | April 6, 2023

Ophelia chanPharma intelligence centerGlobaldata pharma intelligence centerPharma intelligence center dealsBusiness fundamentals analystPrime medicineGlobaldata plc stock exchangePress releaseAys data gb00b87ztg26

GlobalData : Dr Reddy s focuses on differentiated portfolio in key therapy areas as part of India growth strategy, says GlobalData

24 Mar, 2023 Dr. Reddy s focuses on differentiated portfolio in key therapy areas as part of India growth strategy, says GlobalData Share . | March 24, 2023

Prashant khadayateJb chemicals pharmaceuticalsGlobaldata pharma intelligence centerTorrent pharmaceuticalsEris lifesciencesPharma analystPharma intelligence centerGlobaldata plc stock exchangePress releaseAys data gb00b87ztg26

vimarsana © 2020. All Rights Reserved.